|
|
 Previous Article | Table of Contents | Next Article 
High Thrombopoietin Production by Hematopoietic Cells Induces a Fatal Myeloproliferative Syndrome in Mice
Jean-Luc Villeval,
Karine Cohen-Solal,
Micheline Tulliez,
Stéphane Giraudier,
Josette Guichard,
Samuel A. Burstein,
Elisabeth M. Cramer,
William Vainchenker, and
Françoise Wendling
From INSERM U362, Institut Gustave Roussy, Villejuif, France, Service d'Anatomopathologie, Hôpital Cochin, Paris, France; and INSERM U91, Hôpital Henri Mondor, Créteil, France.
To evaluate the effects of long-term, high-dose exposure to thrombopoietin (TPO), lethally irradiated mice were grafted with bone marrow cells infected with a retrovirus carrying the murine TPO cDNA. Mice were studied for 10 months after transplantation. In plasma, TPO levels were highly elevated (104 U/mL) throughout the course of the study. All mice developed a lethal myeloproliferative disorder evolving in two successive phases. During the first phase (7-9 weeks posttransplant), platelet and white blood cell (WBC) counts rose four- and ten-fold, respectively, whereas hematocrits decreased slightly to 29% ± 3%. The WBC were mainly mature granulocytes, but myeloid precursor cells were invariably observed as well as giant platelets with an irregular granule distribution. The striking features were a massive hyperplasia of megakaryocytes and granulocytes in the spleen and bone marrow and a hypoplasia of erythroblasts in bone marrow. Total numbers of megakaryocyte colony-forming cell, burst-forming unit-erythroid, and granulocytemacrophage colony-forming cells were increased but colony-forming unit-erythroid numbers decreased. From 10 weeks posttransplant and thereafter, WBC, platelets, and red blood cell numbers declined dramatically. The absolute numbers of progenitor cells were very low in the spleen and bone marrow, but sharply increased in the blood and peritoneal cavity. Extramedullary hematopoiesis was observed in several organs. Histologic sections of the spleen and bones revealed severe fibrosis and osteosclerosis. The mean survival time was 7 months posttransplant and mice died with severe pancytopenia. Notably, two mice died between 3 and 4 months posttransplant with a leukemic transformation. This disorder was transplantable into secondary recipients who developed an attenuated form of the disease similar to the one previously described (Yan et al, Blood 86:4025, 1995). Taken together, our data show that high and persistent TPO production by transduced hematopoietic cells in mice results in a fatal myeloproliferative disorder that has a number of features in common with human idiopathic myelofibrosis.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4369-4383
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. J. Kuter, G. J. Mufti, B. J. Bain, R. P. Hasserjian, W. Davis, and M. Rutstein
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
Blood,
October 29, 2009;
114(18):
3748 - 3756.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Huang, M. Yu, T. E. Akie, T. B. Moran, A. J. Woo, N. Tu, Z. Waldon, Y. Y. Lin, H. Steen, and A. B. Cantor
Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development
Mol. Cell. Biol.,
August 1, 2009;
29(15):
4103 - 4115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. T. Chou, E. Khandros, L. C. Bailey, K. E. Nichols, C. R. Vakoc, Y. Yao, Z. Huang, J. D. Crispino, R. C. Hardison, G. A. Blobel, et al.
Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate
Blood,
July 30, 2009;
114(5):
983 - 994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. N. Constantinescu
Mpl and thrombocytosis: levels matter
Blood,
February 19, 2009;
113(8):
1617 - 1618.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pancrazzi, P. Guglielmelli, V. Ponziani, G. Bergamaschi, A. Bosi, G. Barosi, and A. M. Vannucchi
A Sensitive Detection Method for MPLW515L or MPLW515K Mutation in Chronic Myeloproliferative Disorders with Locked Nucleic Acid-Modified Probes and Real-Time Polymerase Chain Reaction
J. Mol. Diagn.,
September 1, 2008;
10(5):
435 - 441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. James
The JAK2V617F Mutation in Polycythemia Vera and Other Myeloproliferative Disorders: One Mutation for Three Diseases?
Hematology,
January 1, 2008;
2008(1):
69 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Wilkins, W. N. Erber, D. Bareford, G. Buck, K. Wheatley, C. L. East, B. Paul, C. N. Harrison, A. R. Green, and P. J. Campbell
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
Blood,
January 1, 2008;
111(1):
60 - 70.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Windahl, M. K. Lagerquist, N. Andersson, C. Jochems, A. Kallkopf, C. Hakansson, J. Inzunza, J.-A. Gustafsson, P. T. van der Saag, H. Carlsten, et al.
Identification of Target Cells for the Genomic Effects of Estrogens in Bone
Endocrinology,
December 1, 2007;
148(12):
5688 - 5695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chaligne, C. James, C. Tonetti, R. Besancenot, J. P. Le Couedic, F. Fava, F. Mazurier, I. Godin, K. Maloum, F. Larbret, et al.
Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis
Blood,
November 15, 2007;
110(10):
3735 - 3743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Garimella, M. A. Kacena, S. E. Tague, J. Wang, M. C. Horowitz, and H. C. Anderson
Expression of Bone Morphogenetic Proteins and Their Receptors in the Bone Marrow Megakaryocytes of GATA-1low Mice: A Possible Role in Osteosclerosis
J. Histochem. Cytochem.,
July 1, 2007;
55(7):
745 - 752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Wagner-Ballon, D. F. Pisani, T. Gastinne, M. Tulliez, R. Chaligne, C. Lacout, F. Aurade, J.-L. Villeval, P. Gonin, W. Vainchenker, et al.
Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice
Blood,
July 1, 2007;
110(1):
345 - 353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Chen, O. Naveiras, A. Balduini, A. Mammoto, M. A. Conti, R. S. Adelstein, D. Ingber, G. Q. Daley, and R. A. Shivdasani
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway
Blood,
July 1, 2007;
110(1):
171 - 179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi
Primary myelofibrosis and its paraneoplastic stromal effects
Haematologica,
May 1, 2007;
92(5):
577 - 579.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Campbell and A. R. Green
The Myeloproliferative Disorders
N. Engl. J. Med.,
December 7, 2006;
355(23):
2452 - 2466.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lacout, D. F. Pisani, M. Tulliez, F. M. Gachelin, W. Vainchenker, and J.-L. Villeval
JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
Blood,
September 1, 2006;
108(5):
1652 - 1660.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Wagner-Ballon, H. Chagraoui, E. Prina, M. Tulliez, G. Milon, H. Raslova, J.-L. Villeval, W. Vainchenker, and S. Giraudier
Monocyte/Macrophage Dysfunctions Do Not Impair the Promotion of Myelofibrosis by High Levels of Thrombopoietin.
J. Immunol.,
June 1, 2006;
176(11):
6425 - 6433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Guyot, K. Murai, Y. Fujiwara, V. Valverde-Garduno, M. Hammett, S. Wells, N. Dear, S. H. Orkin, C. Porcher, and P. Vyas
Characterization of a Megakaryocyte-specific Enhancer of the Key Hemopoietic Transcription Factor GATA1
J. Biol. Chem.,
May 12, 2006;
281(19):
13733 - 13742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi
Pathogenesis of Myelofibrosis With Myeloid Metaplasia
J. Clin. Oncol.,
November 20, 2005;
23(33):
8520 - 8530.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Kuhl, A. Atzberger, F. Iborra, B. Nieswandt, C. Porcher, and P. Vyas
GATA1-Mediated Megakaryocyte Differentiation and Growth Control Can Be Uncoupled and Mapped to Different Domains in GATA1
Mol. Cell. Biol.,
October 1, 2005;
25(19):
8592 - 8606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vannucchi, A. Pancrazzi, P. Guglielmelli, S. Di Lollo, C. Bogani, G. Baroni, L. Bianchi, A. R. Migliaccio, A. Bosi, and F. Paoletti
Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic Myelofibrosis
Am. J. Pathol.,
September 1, 2005;
167(3):
849 - 858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kakitani, T. Oshima, K. Horikoshi, T. Yoshitome, A. Ueda, M. Kajikawa, Y. Iba, Y. Ozone, Y. Ijima, T. Yoshino, et al.
A novel transgenic chimaeric mouse system for the rapid functional evaluation of genes encoding secreted proteins
Nucleic Acids Res.,
May 24, 2005;
33(9):
e85 - e85.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vannucchi, L. Bianchi, F. Paoletti, A. Pancrazzi, E. Torre, M. Nishikawa, M. Zingariello, A. Di Baldassarre, R. A. Rana, R. Lorenzini, et al.
A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-{beta}1 in the development of myelofibrosis
Blood,
May 1, 2005;
105(9):
3493 - 3501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Komura, C. Tonetti, V. Penard-Lacronique, H. Chagraoui, C. Lacout, J. P. LeCouedic, P. Rameau, N. Debili, W. Vainchenker, and S. Giraudier
Role for the Nuclear Factor {kappa}B Pathway in Transforming Growth Factor-{beta}1 Production in Idiopathic Myelofibrosis: Possible Relationship with FK506 Binding Protein 51 Overexpression
Cancer Res.,
April 15, 2005;
65(8):
3281 - 3289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Chagraoui, M. Tulliez, T. Smayra, E. Komura, S. Giraudier, T. Yun, N. Lassau, W. Vainchenker, and F. Wendling
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
Blood,
April 15, 2003;
101(8):
2983 - 2989.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood,
December 15, 2002;
100(13):
4272 - 4290.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Chagraoui, E. Komura, M. Tulliez, S. Giraudier, W. Vainchenker, and F. Wendling
Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice
Blood,
November 15, 2002;
100(10):
3495 - 3503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Giraudier, H. Chagraoui, E. Komura, S. Barnache, B. Blanchet, J. P. LeCouedic, D. F. Smith, F. Larbret, A.-L. Taksin, F. Moreau-Gachelin, et al.
Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
Blood,
September 26, 2002;
100(8):
2932 - 2940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Dorsch, G. Zheng, D. Yowe, P. Rao, Y. Wang, Q. Shen, C. Murphy, X. Xiong, Q. Shi, J.-C. Gutierrez-Ramos, et al.
Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease
Blood,
August 28, 2002;
100(6):
2046 - 2055.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vannucchi, L. Bianchi, C. Cellai, F. Paoletti, R. A. Rana, R. Lorenzini, G. Migliaccio, and A. R. Migliaccio
Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice)
Blood,
July 30, 2002;
100(4):
1123 - 1132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Cantor, S. G. Katz, and S. H. Orkin
Distinct Domains of the GATA-1 Cofactor FOG-1 Differentially Influence Erythroid versus Megakaryocytic Maturation
Mol. Cell. Biol.,
June 15, 2002;
22(12):
4268 - 4279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Katz, A. B. Cantor, and S. H. Orkin
Interaction between FOG-1 and the Corepressor C-Terminal Binding Protein Is Dispensable for Normal Erythropoiesis In Vivo
Mol. Cell. Biol.,
May 1, 2002;
22(9):
3121 - 3128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Saleque, S. Cameron, and S. H. Orkin
The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages
Genes & Dev.,
February 1, 2002;
16(3):
301 - 306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vyas, F. A. Norris, R. Joseph, P. W. Majerus, and S. H. Orkin
Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1
PNAS,
November 16, 2000;
(2000)
250476397.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Schmitt, H. Jouault, J. Guichard, F. Wendling, A. Drouin, and E. M. Cramer
Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis
Blood,
August 15, 2000;
96(4):
1342 - 1347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lecine, J. E. Italiano Jr, S.-W. Kim, J.-L. Villeval, and R. A. Shivdasani
Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2
Blood,
August 15, 2000;
96(4):
1366 - 1373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi
Myelofibrosis with Myeloid Metaplasia
N. Engl. J. Med.,
April 27, 2000;
342(17):
1255 - 1265.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Yagi, K. A. Ritchie, E. Sitnicka, C. Storey, G. J. Roth, and S. Bartelmez
Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
PNAS,
July 6, 1999;
96(14):
8126 - 8131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Cohen-Solal, N. Vitrat, M. Titeux, W. Vainchenker, and F. Wendling
High-Level Expression of Mpl in Platelets and Megakaryocytes Is Independent of Thrombopoietin
Blood,
May 1, 1999;
93(9):
2859 - 2866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vyas, K. Ault, C. W. Jackson, S. H. Orkin, and R. A. Shivdasani
Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets
Blood,
May 1, 1999;
93(9):
2867 - 2875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lecine, V. Blank, and R. Shivdasani
Characterization of the Hematopoietic Transcription Factor NF-E2 in Primary Murine Megakaryocytes
J. Biol. Chem.,
March 27, 1998;
273(13):
7572 - 7578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vyas, F. A. Norris, R. Joseph, P. W. Majerus, and S. H. Orkin
Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1
PNAS,
December 5, 2000;
97(25):
13696 - 13701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
